Healthcare -
Biotechnology - NASDAQ - US
$ 54.0
-1.66 %
$ 3.37 B
Market Cap
-12.44
P/E
RYTM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RYTM - Rhythm Pharmaceuticals, Inc.
74.4 M
LAST VALUE
-33.16%
2 YEAR CAGR
-14.70%
5 YEAR CAGR
14.10%
10 YEAR CAGR